內地外資保險公司管理條例細則:人身險公司外方股比放寬至51%
中國銀保監會發布外資保險公司管理條例實施細則,放寬了外資人身險公司外方股比限制,將外資人身險公司外方股比放寬至51%,並為2020年適時全面取消外方股比限制預留制度空間。
細則顯示,將放寬外資保險公司准入條件,落實「在全國範圍內取消外資保險機構設立前需開設兩年代表處的要求」及「取消30年經營年限要求」。
在分支機構管理方面,外資保險公司分支機構的設立和管理方面與中資保險公司均適用《保險公司分支機構市場准入管理辦法》等相關規定,確保在統一規則下開展合作與競爭。
在中國申請人的資格管理方面,明確設立合資保險公司的中國申請人的條件和管理統一適用《保險公司股權管理辦法》,確保相關監管規定的協調統一。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.